O. Wiest

Publications216
h-index42
Citations8,178
Highly Influential Citations327
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • P. Norrby
  • 239 Publications, 6,136 Citations
  • K. Houk
  • 1,263 Publications, 51,243 Citations
  • P. Helquist
  • 271 Publications, 4,029 Citations
  • M. Sigman
  • 314 Publications, 11,646 Citations
  • Publications
  • Influence
Selective inhibition of BET bromodomains
Epigenetic proteins are intently pursued targets in ligand discovery. So far, successful efforts have been limited to chromatin modifying enzymes, or so-called epigenetic ‘writers’ and ‘erasers’.… Expand
  • 2,566
  • 216
  • PDF
A molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria
Artemisinins are the cornerstone of anti-malarial drugs. Emergence and spread of resistance to them raises risk of wiping out recent gains achieved in reducing worldwide malaria burden and threatens… Expand
  • 374
  • 28
  • PDF
Histone deacetylase inhibitor treatment dramatically reduces cholesterol accumulation in Niemann-Pick type C1 mutant human fibroblasts
Niemann-Pick type C (NPC) disease is predominantly caused by mutations in the NPC1 protein that affect intracellular cholesterol trafficking and cause accumulation of unesterified cholesterol and… Expand
  • 165
  • 8
  • PDF
Blueprint for antimicrobial hit discovery targeting metabolic networks
  • Y. Shen, J. Liu, +7 authors Z. Oltvai
  • Biology, Medicine
  • Proceedings of the National Academy of Sciences
  • 5 January 2010
Advances in genome analysis, network biology, and computational chemistry have the potential to revolutionize drug discovery by combining system-level identification of drug targets with the… Expand
  • 97
  • 6
  • PDF
Computational studies of the cholesterol transport between NPC2 and the N-terminal domain of NPC1 (NPC1(NTD)).
The transport of cholesterol from NPC2 to NPC1 is essential for the maintenance of cholesterol homeostasis in late endosomes. On the basis of a rigid docking model of the crystal structures of the… Expand
  • 29
  • 5
Structural origin of selectivity in class II-selective histone deacetylase inhibitors.
The development of class- and isoform-selective histone deacetylase (HDAC) inhibitors is highly desirable for the study of the complex interactions of these proteins central to transcription… Expand
  • 101
  • 4
Toward selective histone deacetylase inhibitor design: homology modeling, docking studies, and molecular dynamics simulations of human class I histone deacetylases.
Histone deacetylases (HDACs) play an important role in gene transcription. Inhibitors of HDACs induce cell differentiation and suppress cell proliferation in tumor cells. Although many HDAC… Expand
  • 176
  • 4
Thiadiazole carbamates: potent inhibitors of lysosomal acid lipase and potential Niemann-Pick type C disease therapeutics.
Niemann-Pick type C (NPC) disease is a lysosomal storage disorder characterized at the cellular level by abnormal accumulation of cholesterol and other lipids in lysosomal storage organelles.… Expand
  • 70
  • 4
  • PDF
The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogs
The cytoplasmic prolyl-tRNA synthetase of Plasmodium falciparum is a dual-stage therapeutic target for drug development. An ancient remedy for a modern scourge Malaria is a devastating disease. It is… Expand
  • 39
  • 4
Discovery of selective small-molecule HDAC6 inhibitor for overcoming proteasome inhibitor resistance in multiple myeloma
Significance Proteasome inhibitors show remarkable anti-multiple myeloma (MM) activity in preclinical and clinical studies. However, resistance develops in the majority of patients, and novel… Expand
  • 60
  • 3